Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
复制标题
基于cell-SELEX技术的核酸适配体在结直肠癌诊治中的应用
DOI:
10.1038/s41698-017-0041-y
复制
发表时间:
2017
影响因子:
7.9
通讯作者:
Tang F
中科院分区:
文献类型:
--
作者:
Chen C;Zhou S;Cai Y;Tang F
Nucleic acid aptamers are a class of high-affinity nucleic acid ligands. They serve as “chemical antibodies” since their high affinity and specificity. Nucleic acid aptamers are generated from nucleic acid random-sequence using a systematic evolution of ligands by exponential enrichment (SELEX) technology. SELEX is a process of effectively selecting aptamers from different targets. A newly developed cell-based SELEX technique has been widely used in biomarker discovery, early diagnosis and targeted cancer therapy, particular at colorectal cancer (CRC). Combined with nanostructures, nano-aptamer-drug delivery system was constructed for drug delivery. Various nanostructures functionalized with aptamers are highly efficient and has been used in CRC therapeutic applications. In the present, we introduce a cell- SELEX technique, and summarize the potential application of aptamers as biomarkers in CRC diagnosis and therapy. And some characteristics of aptamer-targeted nanocarriers in CRC have been expatiated. The challenges and perspectives for cell-SELEX are also discussed.
登录
查看更多内容
影响因子:
5.1
作者:
Ahn, Chang-Bum;Jung, Won-Kyo;Je, Jae-Young
通讯作者:
Je, Jae-Young
影响因子:
14.9
作者:
Ferreira CS;Cheung MC;Missailidis S;Bisland S;Gariépy J
通讯作者:
Gariépy J
DOI:
10.3390/ph9020029
发表时间:
2016-05-19
期刊:
Pharmaceuticals (Basel, Switzerland)
影响因子:
--
作者:
Gijs M;Penner G;Blackler GB;Impens NR;Baatout S;Luxen A;Aerts AM
通讯作者:
Aerts AM
影响因子:
6.1
作者:
Cao, Hongmei;Fang, Xueen;Kong, Jilie
通讯作者:
Kong, Jilie
影响因子:
4.8
作者:
Boltz, Achim;Piater, Birgit;Hock, Bjoern
通讯作者:
Hock, Bjoern